Today: 8 June 2026
BCE price target shake-up: RBC lifts to C$38 as Scotiabank, Desjardins trim theirs
15 January 2026
2 mins read

BCE price target shake-up: RBC lifts to C$38 as Scotiabank, Desjardins trim theirs

Toronto, Jan 15, 2026, 10:58 EST

  • RBC Capital Markets nudged up its price target for BCE to C$38 from C$37, maintaining its Outperform rating.
  • Both Scotiabank and Desjardins cut their targets for BCE but kept their positive ratings intact.
  • In Toronto’s morning session, BCE shares hovered near C$33.6.

RBC Capital Markets bumped up its price target on BCE Inc to C$38 from C$37 on Tuesday, maintaining its Outperform rating. The upgrade reflects expectations for a boost in operating growth next year. BCE shares were trading near C$33.6 on the Toronto Stock Exchange Thursday morning.

BCE’s three-year forecast has become the linchpin of the story: growth either bounces back in 2026, or the stock remains stuck at a low valuation. In Canada, many investors still see BCE as a reliable dividend play, so any change in cash-flow expectations spreads quickly.

Targets have shifted in opposite directions, yet the mood remains steady. Scotiabank and Desjardins both trimmed their forecasts earlier this week but stuck to optimistic ratings. Investors are left with the usual divide: value looks attractive to some, while others fret over balance-sheet strength and execution risks.

RBC projects underlying revenue and adjusted EBITDA will pick up again starting in 2026. Adjusted EBITDA, which excludes interest, taxes, depreciation, and amortization, is often adjusted by firms and analysts to highlight core operating results.

The bank highlighted key growth drivers like Ziply, enterprise services, and Bell Media. It added that BCE’s 2026–2028 outlook might boost earnings visibility compared to Canadian peers, potentially leading to modest “multiple expansion” — where investors assign a higher valuation to the same earnings.

On Monday, Scotiabank analyst Maher Yaghi lowered his price target to C$40.75 from C$41.50 but maintained an Outperform rating, MarketBeat reported in a note shared on TipRanks.

On Monday, Desjardins cut its price target for BCE to C$41 from C$42 but kept a buy rating, MarketBeat reported. At that time, MarketBeat valued BCE at about C$33 and flagged the company’s heavy leverage, noting a debt-to-equity ratio near 226.7 and a slim net margin of roughly 1.1%.

Desjardins Securities analyst Jerome Dubreuil views the upcoming guidance update as an early checkpoint for BCE’s three-year EBITDA growth target of 2% to 3%. He described himself as “constructive on the name given the compelling Ziply expansion opportunity, improving operations in Canada, better visibility and an attractive relative valuation.” https://www.stockwatch.com/News/Item/Z-C%2…

That upside, however, hinges on execution rather than numbers alone. If the anticipated 2026 growth acceleration fails to materialize in guidance or earnings, it’s tough to justify investors paying a premium for BCE, despite targets remaining well above its current share price.

BCE, Rogers, and Telus lead Canada’s telecom market, and the recent target revisions highlight brokers’ shifting stances heading into 2026. According to TipRanks data, BCE’s price targets still vary considerably, even though a majority of analysts maintain buy-equivalent ratings.

Stock Market Today

  • Greggs Shares Rally Nearly 20% in One Month: Is It Time to Buy?
    June 8, 2026, 3:44 AM EDT. Greggs (LSE:GRG) shares surged 18.5% from May 5-27, driven by promising May trading updates showing 2.5% like-for-like sales growth in the first 19 weeks of 2026, accelerating to 3.3% in the last 10 weeks. The bakery chain expanded its store network to 2,759 locations, boosting its market reach. While the brand's innovation and extended trading hours offer long-term potential, near-term risks include consumer spending pressure and cost inflation squeezing margins. Despite signs of improvement, analysts advise cautious monitoring rather than immediate buying amid economic uncertainties.

Latest articles

Snap Drops 5%—Ad Recovery Eyed Next

Snap Drops 5%—Ad Recovery Eyed Next

8 June 2026
Snap closed Friday at $5.76, down 5.11% amid a broad tech selloff triggered by a strong jobs report and renewed rate-hike worries, but still ended the week up 0.9%. Investors now await U.S. inflation data and CEO Evan Spiegel’s June 16 AWE keynote on Specs, as Snap faces pressure from weak North American ad revenue, tough competition, and activist demands for cost cuts.
Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

8 June 2026
Navitas plunged $5.61 to $25.08 Friday as a $1.3 trillion chip selloff erased Nvidia-driven gains, despite news it issued 3.28 million shares for merger earn-outs and showcased its GaNFast power board at Nvidia’s AI MGX event; investors now face risks from share dilution, sector volatility, and Navitas’s early-stage pivot to high-power AI markets amid ongoing operating losses.
NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

8 June 2026
NIO’s U.S.-listed shares plunged 5.8% Friday, erasing a delivery-led rally, as investors focus on whether June sales can hit the company’s Q2 target after May deliveries rose 62.3% to 37,705. NIO needs 42,939–47,939 June deliveries to meet guidance, with risks from China’s saturated car market and recent price pressure.
HPE Stock Faces AI Rally Test With Monday In Focus

HPE Stock Faces AI Rally Test With Monday In Focus

8 June 2026
Hewlett Packard Enterprise plunged 8.36% Friday to $49.20, capping a three-day slide and erasing gains after a post-earnings surge, even as it raised its fiscal 2026 revenue growth outlook to 29%-33% and boosted non-GAAP EPS guidance, with analysts warning that rapid gains may have priced in too much hope too quickly.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop